BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 12077349)

  • 1. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
    Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
    Mol Cell Biol; 2002 Jul; 22(14):5222-34. PubMed ID: 12077349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
    Takahashi Y; Toh-E A; Kikuchi Y
    J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
    Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
    J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.
    Hattori T; Eberspaecher H; Lu J; Zhang R; Nishida T; Kahyo T; Yasuda H; de Crombrugghe B
    J Biol Chem; 2006 May; 281(20):14417-28. PubMed ID: 16554309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
    Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
    J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
    Rogers RS; Horvath CM; Matunis MJ
    J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
    Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
    Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
    Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
    Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIAS proteins promote SUMO-1 conjugation to STAT1.
    Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
    Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
    Palvimo JJ
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1405-8. PubMed ID: 18031232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family.
    van den Akker E; Ano S; Shih HM; Wang LC; Pironin M; Palvimo JJ; Kotaja N; Kirsh O; Dejean A; Ghysdael J
    J Biol Chem; 2005 Nov; 280(45):38035-46. PubMed ID: 16148010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIAS/SUMO: new partners in transcriptional regulation.
    Schmidt D; Müller S
    Cell Mol Life Sci; 2003 Dec; 60(12):2561-74. PubMed ID: 14685683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.